A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
Flavio Vincenti(University of California, San Francisco), B Charpentier(Inserm), Yves Vanrenterghem(KU Leuven), Lionel Rostaing(Inserm), Barbara A. Bresnahan(Medical College of Wisconsin), P. Darji(Sterling Hospitals), P. Massari(Hospital Privado), G. Mondragon-Ramirez, Mamta Agarwal(Bristol-Myers Squibb (United States)), G. Russo(Bristol-Myers Squibb (United States)), C.‐S. Lin(Bristol-Myers Squibb (United States)), Pushkal Garg(Bristol-Myers Squibb (United States)), Christian P. Larsen(Emory University)
Cited by 941
Abstract
Related Papers
No related papers found
Powered by citation graph analysis